Stay updated on Imatinib in Recurrent Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.

Latest updates to the Imatinib in Recurrent Psoriasis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a platform-level update. No study content or visible information appears to have changed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now shows Revision: v3.6.4, signaling a minor update to the page version. This change does not modify study content or user-facing information.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This change updates the page's revision tag and does not alter study content or functionality.SummaryDifference0.1%

- Check53 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2. This indicates a maintenance or patch release of the page and does not change the study content or eligibility details.SummaryDifference0.1%

- Check67 days agoChange DetectedThe study page now shows recruitment has ended ('No longer looking for participants'), and new help/navigation sections such as How to Read a Study Record, Common Questions, and How to Join a Study have been added.SummaryDifference0.5%

- Check74 days agoChange DetectedA new page revision tag appears at the bottom: Revision: v3.5.5, replacing Revision: v3.5.4, indicating an updated page build.SummaryDifference0.1%

Stay in the know with updates to Imatinib in Recurrent Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.